Stay updated with breaking news from Nasdaq Spro. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Spero Therapeutics, Inc. (NASDAQ:SPRO – Get Rating) saw a significant growth in short interest in March. As of March 31st, there was short interest totalling 1,580,000 shares, a growth of 67.6% from the March 15th total of 942,700 shares. Based on an average daily volume of 567,500 shares, the days-to-cover ratio is currently 2.8 days. […]
Spero Therapeutics, Inc. (NASDAQ:SPRO – Get Rating) was the target of a large growth in short interest in March. As of March 31st, there was short interest totalling 1,580,000 shares, a growth of 67.6% from the March 15th total of 942,700 shares. Based on an average daily volume of 567,500 shares, the days-to-cover ratio is […]
HC Wainwright restated their buy rating on shares of Spero Therapeutics (NASDAQ:SPRO – Get Rating) in a report published on Monday, Benzinga reports. HC Wainwright currently has a $6.00 target price on the stock. HC Wainwright also issued estimates for Spero Therapeutics’ Q1 2023 earnings at ($0.43) EPS, Q2 2023 earnings at ($0.43) EPS, Q3 […]
Spero Therapeutics, Inc. (NASDAQ:SPRO – Get Rating) was the recipient of a significant increase in short interest in March. As of March 15th, there was short interest totalling 942,700 shares, an increase of 142.0% from the February 28th total of 389,500 shares. Based on an average trading volume of 459,100 shares, the days-to-cover ratio is […]
At the end of the latest market close, Spero Therapeutics Inc. (SPRO) was valued at $0.82. In that particular session, Stock kicked-off at the price of $0.881 while reaching the peak value of $0.90 and lowest value recorded on the day was $0.81. The stock current value is $2.62.Recently in News on S